Research output per year
Research output per year
-
Design of CellProfiler-based pipelines enabling the attribution of molecular stress markers to specific tissue and subcellular compartments of the colonic mucosa
Hödlmayr, H., Watschinger, C., Wallner, G. K., Knipp, S., Rohwedder, A., Prommer, R., Langer, R. & Moschen, A. R., 2026, In: Cellular and Molecular Gastroenterology and Hepatology. 20, 6, 44 p., 101680.Research output: Contribution to journal › Article › peer-review
Open Access -
Management of major complications after hepatectomy
Sokolovski, F., Jagoditsch, A., Kienberger, G., Raab, S., Trattnig, R., Scotton, G., Szabo, K., Rathenböck, M. D., Loschko, N., Pimingstorfer, P., Hagleitner, G., Schmit, P., Moschen, A. R., Shamiyeh, A. & Stättner, S., 05 Nov 2025, (E-pub ahead of print) In: European Surgery - Acta Chirurgica Austriaca.Research output: Contribution to journal › Article › peer-review
Open Access -
Transhepatic embolization of jejunal variceal bleeding in a patient with liver cirrhosis: a case report
Rathenböck, M. D., Hagleitner, G., Pichler, P., Szabo, K., Moschen, A., Shamiyeh, A. & Fellner, F., Dec 2025, In: Wiener klinische Wochenschrift. 137, 23-24, p. 793-797 5 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Filgotinib bei Colitis ulcerosa: ein Review
Translated title of the contribution :Filgotinib in Ulcerative Colitis: a review Research output: Contribution to journal › Article › peer-review
Open Access -
FRI-394 High burden of cirrhosis and increasing response rates to bulevirtide-based regimens: insights from the austrian prospective hepatitis D registry
Schwarz, M., Schwarz, C., Bauer, D., Panzer, M., Strasser, M., Reiter, S., Moschen, A. & et al., Jun 2024, 2 p.Research output: Other contribution
-
CHARGE: A Phase 3b, Multicenter, Randomized, Open-Label, Active-Controlled Study to Compare the Efficacy and Safety of Guselkumab versus Risankizumab in the Treatment of Participants with Moderately to Severely Active Crohn’s Disease
Moschen, A. (PI), Kainberger, M. (Administration), Doringer, D. (Administration), Prommer, R. (Researcher), Rathenböck, M. (Researcher) & Klenske, E. (Researcher)
01.04.2026 → 23.04.2030
Project: Clinical studies › Clinical Study (Industry project)
-
VICTRIVA: A Randomized, Double-blind, Phase 3b Study to Evaluate the Short- and Long-term Efficacy and Safety of Dual Targeted Therapy With lntravenous Vedolizumab and Oral Upadacitinib Compared With lntravenous Vedolizumab and Oral Placebo for lnduction Followed by lntravenous Vedolizumab Monotherapy for Maintenance in the Treatment of Adults With Moderately to Severely Active Crohn's Disease
Moschen, A. (PI), Prommer, R. (Co-PI), Klenske, E. (Researcher), Pimingstorfer, P. (Researcher), Rathenböck, M. D. (Researcher), Kainberger, M. (Administration), Zaunmair, P. (Administration) & Doringer, D. (Administration)
28.03.2025 → 27.03.2030
Project: Clinical studies › Clinical Study (Industry project)
-
Cluster of Excellence “Microbiomes Drive Planetary Health"
Moschen, A. (Researcher), Wagner, M. (PI) & Hinterdorfer, P. (Researcher)
01.10.2023 → 30.09.2028
Project: Funded research › FWF - Austrian Science Fund
-
Roche_NK cells in IBD
Moschen, A. (PI)
14.01.2021 → 14.01.2022
Project: Funded research › Other sponsors
-
CD Laboratory for Mucosal Immunology
Moschen, A. (PI) & Moschen, A. (PI)
01.01.2017 → 31.12.2023
Project: Funded research › CDG - Christian Doppler Research Association
Activities
-
Ontunisertib – ALK5-Blockade bei fistulierendem Morbus Crohn
Moschen, A. (Speaker)
18 Feb 2026Activity: Talk or presentation › Invited talk › science-to-science
-
GUS Advisory Board - Johnson & Johnson
Moschen, A. (Participant)
04 Dec 2025Activity: Participating in or organising an event › Participating in a conference, workshop, ...
-
TASC Meeting 2025 - Johnson & Johnson
Moschen, A. (Participant)
21 Nov 2025Activity: Participating in or organising an event › Participating in a conference, workshop, ...
-
CE&B IBD Standalone - Johnson & Johnson
Moschen, A. (Participant)
14 Nov 2025 → 15 Nov 2025Activity: Participating in or organising an event › Participating in a conference, workshop, ...
-
Inkrementelle Dialyse - Wo stehen wir 2025?
Moschen, A. (Speaker)
13 Nov 2025Activity: Talk or presentation › Invited talk › science-to-science